What is clear from published phase 2 data is that diarrhoea is among the most commonly reported adverse effects, particularly during the early weeks of treatment and following each dose increase
The Biochemical journal, 282 ( Pt 1)(Pt 1), 9197
In the Phase 2 obesity trial (Jastreboff et al., New England Journal of Medicine , 2023), investigators reported dose-dependent mean weight reduction of up to 17.5% at 24 weeks and up to 24.2% at 48 weeks
In experimental settings, this combination is used to study appetite regulation, energy expenditure, glucose handling and metabolic signaling integration
When you first wake up, your body is in a fasted state, which creates a specific set of conditions that can be highly beneficial for supplement intake